Джейн Плант - Антирак груди

http://cis.nci.nih.gov/fact/7_45.htm

New Scientist , 20 January, 2007.

Editorial, New Scientist , 31 March, 2007.

Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ , 324, 1113.

Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ , 325, 269–271.

www.cancer.gov

Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99 – 1136: www.cancer.gov/cancerinfo/chemorherapy-and-you

Smith, I. and Chue, S., 2006. Medical treatment of early breast cancer. BMJ , 332, 162–181.

Allison, R. and others, 2006. Photodiagnosis and photodynamic therapy, 3, 139–146.

Fritsch, C. and Ruzika, T., 2003. Fluorescence diagnosis and photodynamic therapy of skin diseases atlas and handbook. Vien: Springer-Verlag.

Абляция (лат. ablatio – отнятие) – специфическое хирургическое вмешательство; абляция подразумевает под собой выжигание или выпаривание дисфункциональной или патологически измененной ткани с использованием лазера, радиочастотного аппарата, тока или химии; также данная операция может проводиться классическим хирургическим вмешательством. – Примеч. ред.

Coulter; Angela, 2003. Killing the goose that laid the golden egg. BMJ , 326, 1280.

Coulter, Angela, 2003. Killing the goose that laid the golden egg. BMJ , 326, 1280.

Ernst, E., 2003. Herbal medicines put into context. BMJ , 327, 881–882.

Waxman, Jonathan, 2001. The Prostate Cancer Book . London: Vermillion.

Dyer, Owen, 2003. Aspirin could be used to prevent cancer. BMJ , 326, 565.

Flower, Rod, 2003. What are all the things that aspirin does? BMJ , 327, 572–573.

UK limits use of aspirin by under 16s. BMJ , 2002, 324, 1294.

Astralagus. ICON , 2002, 1 (3), 23.

Bartram, T., 1998. Bartram's encyclopedia of herbal medicine . Robinson publishing.

Campbell, T. C. and Campbell, T. M., 2006. The China Study . Benbella Books.

Рейки – вид комплементарной медицины, в котором используется техника так называемого исцеления путем наложения рук. – Примеч. ред.

Greenwald, Peter, 2002. Cancer chemoprevention. BMJ , 324, 714–718.

Clarke, M.F. and Becker, M.W., 2006. Stem cells: the real culprits in cancer? Scientific American , July 2006, 53–59.

Study reveals how growth factors affect human stem cells. www.hhmi.org/news/melton.hmtl

Murray, R.K., Granner, D.K., Mayes, P.A. and Rodwell, V.W., 1990. Harper's Biochemistry . Appleton and Lange Norwalk, CT, p. 653.

Woolf, Neville, 1998. Pathology, Basic and Systemic . W.B. Saunders Publishing Co., Chapter 28, p. 274, Figure 28.

www.intouchlive.com/cancergenetics/onco.htm

Ludwig, T., Fisher, P., Ganesan, S. and Efstratiadis, 2001. Tumorigenesis in mice carrying a truncating BRCA1 mutation. Genes and Development , Vol. 15 (10), 1188–1193.

Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A. and Deng, C.X. 1999. Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genetics , Vol. 22 (1), 37–43.

Paull, T.T, Cortez, D., Bowers, B., Elledge, S.J. and Gellert, M., 2001. Direct DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the USA , Vol. 98 (11), 6086–6091.

Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, B., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin. Nature Genetics , 12, 303–308; www.mc.vanderbilt.edu/cancer/research/roster/jensen.html

Struewing, J.P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi-Jewish individuals. Nature Genetics , 11, 198–200; http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html

Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics , 14, 185–187; Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Vrody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P. Jhanwar, S., Golgar, D., Ostrer, H. and Offit, K., 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 %. Nature Genetics , 14, 188–190; http://rex.nci.nih.gov/massmedia/backgrounders/ashkenazi.html

www.mercola.com/2002/apr/27/sv40.htm

Hursting, S.D., Slaga,T.J., Fischer, S.M., DiGiovanni, J. and Phtans, J. M., 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. Journal of the National Cancer Institute , 35, 2031–2038.

Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine . Churchill Livingston.

Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine . Churchill Livingston.

Stewart, H.J., 1989. Clinical experience in the use of antioestrogen tamoxifen in the treatment of breast cancer. Proceedings of the Royal Society of Edinburgh , 95B, 231–237.

Miller, W. R., 1997. Aromatase inhibitors and breast cancer. Cancer Treatment Reviews , 23, 113–131.

Dao, T.L., Sinha, D.K., Nemato, T. and Patel, J., 1982. Effects of estrogens and progesterone on cellular replication of human breast tumours. Cancer Research , 42, 359–362.

Conte, P.P., Fraschini, G. and Dewinko, B., 1985. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer. Journal of Steroid Biochemistry , 23, 1169–1172.